Overview
This trial studies how well a multilevel human papillomavirus (HPV) self-testing intervention works in increasing cervical cancer screening among women in Appalachia. Most cases of cervical cancer occur among unscreened and underscreened women. A multilevel HPV self-testing intervention may help to improve cervical cancer screening rates.
Description
PRIMARY OBJECTIVES:
Determine the effectiveness of the intervention in increasing cervical cancer screening.
OUTLINE: Participants are randomized to 1 of 2 groups.
GROUP I: Participants receive the HPV self-testing intervention consisting of mailed HPV self-test devices. Participants also receive an information about cervical cancer. Participants who do not return their self-test within a few weeks receive telephone-based patient navigation.
GROUP II: Participants receive usual care consisting of a reminder letter to get a clinic-based cervical cancer screening test and information about cervical cancer.
Eligibility
Inclusion Criteria:
- Not within recommended cervical cancer screening guidelines for women in this age range (i.e., no Papanicolaou [Pap] test in last 3 years or no Pap test plus clinic-based HPV test in last 5 years)
- Resident of an Appalachian county
- Not currently pregnant
- Intact cervix
- No history of invasive cervical cancer
- Seen in a participating clinic/health system in last 2 years (i.e., active patient)
- Have a working telephone